| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2009.12.065 |
| P698 | PubMed publication ID | 20056183 |
| P50 | author | Satya Parida | Q43196653 |
| Bryan Charleston | Q61162596 | ||
| P2093 | author name string | B Veronica Carr | |
| Helen Prentice | |||
| David J Paton | |||
| Sarah J Cox | |||
| Paul V Barnett | |||
| Pip A Hamblin | |||
| P2860 | cites work | FMD vaccines | Q35044859 |
| Developments in foot-and-mouth disease vaccines | Q36395476 | ||
| Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review | Q37224088 | ||
| Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines. | Q41345772 | ||
| Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier' and "non-carrier' cattle | Q42128756 | ||
| Growth of foot-and mouth disease virus in monolayer cultures of calf thyroid cells | Q44399792 | ||
| Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes | Q44772070 | ||
| High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus | Q45396763 | ||
| Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance | Q45423544 | ||
| Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach | Q46793625 | ||
| Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines | Q57105182 | ||
| Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle | Q57169982 | ||
| The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle | Q71275847 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2318-2322 | |
| P577 | publication date | 2010-01-05 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve | |
| P478 | volume | 28 |
| Q38151208 | A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance |
| Q40531326 | Evaluation of the efficacy of a new oil-based adjuvant ISA 61 VG FMD vaccine as a potential vaccine for cattle |
| Q42176472 | Genetic and immunologic relationships between vaccine and field strains for vaccine selection of type A foot-and-mouth disease virus circulating in East Asia |
| Q34427059 | Interferon-γ induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection |
| Q36621746 | Mass vaccination, immunity and coverage: modelling population protection against foot-and-mouth disease in Turkish cattle |
| Q35101293 | Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey. |
| Q27677139 | Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen |
| Q45325592 | Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle |
| Q42282356 | The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease. |
| Q57469674 | Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine |
Search more.